LB Pharmaceuticals Stock (NASDAQ:LBRX)
Previous Close
$15.97
52W Range
$13.36 - $20.25
50D Avg
$15.82
200D Avg
$15.82
Market Cap
$374.80M
Avg Vol (3M)
$297.23K
Beta
-
Div Yield
-
LBRX Company Profile
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.